FOR SALE: New growth plate fixation product

Streamers… I  am passing along a new product that is available for sale or licensing.  See message below.
—————————-
I am Mauricio Toro from Industrias Médicas Sampedro a small trauma manufacturer in Colombia that has been working very hard on establishing an R&D system that focuses on enhanced surgical planning by use of 3D printing and novel technologies that make surgeries easier. I am an avid reader of your blog and want to share with you a product that we have developed and has a PCT patent pending. Our product is called Epiflex, it is an infinitely flexible growth control plate that is based on cables and two loops for the screws. This flexibility allows for larger corrections, for more a more anatomical plate position and for an extremely low contact implant in the physis. We developed this product for our own portfolio, but we only sell our products in Colombia and believe this product has a larger potential audience. With your contact list I thought you might be interested in discussing potential ways to approach orthopedic companies that might be interested in licensing or buying the technology.
We will have a booth in AAOS Booth 3051 and if you have time, it would be very interesting to have a chat and let me show you the prototypes and other interesting tech we have developed.
Thank you in advance for any help you can offer.
While I am at AAOS my phone number is +1 (929) 248-8135 and anyone interested can stop by our booth.  After AAOS, they can contact me at [email protected] or they can contact me on linkedin
http://linkedin.com/in/mauricio-toro-76855514

Read More

FOR SALE: Low cost implant company with hip and knee systems

NovoSource Prepares to Liquidate Corporate Assets (HealthPointCapital)
NovoSource heads to bankruptcy auction (MassDevice)
Orthopedic developer NovoSource said this week it will be liquidating its corporate assets through a court-ordered auction some time in late spring.
The Dayton, Ohio-based medical device maker’s primary products were the NovoKnee total knee system and the NovoHip total hip system.
NovoSource offers a posterior stabilized option for its NovoKnee femoral components, as well as a cruciate retaining design. Its posterior stabilized, cruciate retaining and ultra congruent highly cross linked polyethylene knee inserts are available in 9mm to 18mm sizes in 2mm increments, the company said.
The company’s NovoHip uses a titanium plasma spray cementless tapered stem with 21 different size variations and offered in multiple shell configurations.
Assets to be offered in the sale include all intellectual property, inventory, tooling, design history files as well as regulatory clearances, trademarks, copyrights, ERP system and servers and warehouse equipment and furniture, with the knee and hip implant inventory valued at over $3 million, according to a press release.
The company has not yet decided on a date for the sale.

 
If interested in bidding on these assets, contact:
Myron Terecky
614-228-6345 office
[email protected]
575 S. Third St
Columbus OH 45215

Read the List of Low Cost Implant Companies

Read More

Orthopedic surgical sophistication through single-use disposable instrumentation

Surgical Sophistication (ODTMag)
Surgical instrumentation continues to be a strong market within the orthopedic industry. Aging baby boomers, who are eager to stay active, are keenly interested in orthopedic products. They have high expectations for joint surgeries; combined with the Affordable Care Act’s emphasis on improved patient outcomes, and cost-saving initiatives by healthcare systems, these impactors drive innovation and sales for orthopedic OEMs and their supply-chain partners.
Growth is also fueled by numerous mergers and acquisitions within the industry. Leaders in the orthopedic space continue to diversify through acquisition so they can capitalize on growth opportunities. With solid business models and proven track records, they can offer a broader line of products, including legacy devices, which generate more sales growth.
For example, Phillips Precision Medicraft, an Elmwood Park, N.J.-based contract manufacturer of advanced orthopedic implants, instruments, and sterilization delivery systems, enjoyed double-digit growth in 2016—in part driven by an increase in legacy products and product transfer activity across its business portfolio. “The growth in legacy products is a result of products surviving the rationalization process after mergers,” said Jack Neenan, vice president of business development for the company. “These products then generally receive increased exposure in the field, with more salespeople marketing the products.”
In general, surgical instrumentation and delivery systems trends support orthopedic industry trends. Hip and knee products are becoming more of a commodity and therefore face greater pricing pressures; extremities and niche products tend to provide more profitable opportunities. Innovation continues to enhance minimally-invasive procedures. The tight tolerances and complex assemblies required for these types of surgical equipment often create unique design and manufacturability challenges for contract manufacturers.
“More complex procedures, value-driven healthcare and miniaturization and robotics-assisted surgery are all driving innovation,” said Alan Connor, CEO for Cadence Inc., a Staunton, Va.-based contract manufacturer for medical device and diagnostics companies.
This innovation also includes an increased interest in single-use instrumentation. Although reusable instruments are high quality and well-suited for the job, they can be difficult to calibrate and clean, which adds time and money to surgery overheads and creates slight but real infection risks. With an emphasis today on cost reduction and improved patient outcomes, as well as the ever-present goal to improve operating room (OR) efficiencies and reduce reprocessing needs, more surgeons are moving toward single-use, disposable instrumentation.
“There is a definite shift toward using disposable sterile-packed instruments and complete procedural kits in the OR,” said James B. Schultz, executive vice president for ECA Medical Instruments Inc., a Thousand Oaks, Calif.-based provider of single-procedure (disposable) torque-limiting instruments, fixed drivers, ratchets, and sterile-packed procedural kits for securing orthopedic and spine implants.
What OEMs Want
Many new product development efforts by orthopedic OEMs target “reducing the total cost of instrumentation or delivery, improving the overall performance of the instrumentation, and/or enabling minimally invasive or computer/robotic-assisted surgery,” said Jodie Gilmore, CEO of Onyx Medical LLC, a Memphis, Tenn.-based manufacturer specializing in bone-cutting, bone-piercing and bone-fixation products and is also a subsidiary of Elos Medtech.
To read the full feature, see it at ODTmag

Read More

I Believe

your Recruiter should be your PARTNER and ADVISOR (not just a transactional agent) for your company.

your Recruiter should bring your company the best possible TALENT for the salary range guidance (not the most convenient resumes on file).

your Recruiter should TALK with a candidate at length and get to know them before presenting their resume to you.

your Recruiter should NAIL DOWN a candidate’s salary expectation well before offer time.

your Recruiter should offer a candidate EXCLUSIVELY to your company (not shop the Candidate around to your competitors).

your Recruiter should GUARANTEE that your new hire has longevity.

your Recruiter should be completely CONFIDENTIAL.

Read More

6 Questions with Curt Wiedenhoefer, an old friend who is bringing wearable patient monitoring to total joints

This is the seventh in a series of 6-Question interviews with the leaders who are challenging conventional thinking in Orthopedics (read other interview here)

I first got to know Curt Wiedenhoefer in 1988 when we were both working with Richards Medical, now Smith & Nephew.  He was a young salesman working in Southern California selling trauma and hip and knee products. Since that time, Curt was recruited to Depuy in Northern California to manage the sales efforts for one of the largest distributorships at the time in the U.S.  While he was working closely with surgeons, he realized there was a need for medical electronics in orthopedics. He founded a company, called Eisenlohr Technologies, Inc. in 1992.  They developed a hand held measuring device for radiographs and an X-Ray marker.  He bootstrapped the product development by collaborating with the PhD electrical engineering program at Stanford University.  Self-funding with a small group of investors, he was able to get the product to market and sold it worldwide. Over the last 12 years he served as the Executive Vice President of Sales and Marketing for Consensus Orthopedics. The past 2 years he has also been the General Manager of the TracPatch division, which focuses on wearable technology in orthopedics.  Recently, he was promoted to President of the Consensus Orthopedics.
I sat down with Curt and asked him a few questions about the new technology Consensus is developing.
1. So Curt, tell me about Consensus Orthopedics and its current trajectory.
Thank you Tiger. We are excited to say this year Consensus will celebrate 25 years in orthopedics!  Our company headquarters is in El Dorado Hills, CA, about 30 miles east of Sacramento in Northern California.  Our primary focus has always been on the hip and knee market and we have been and will continue to be, a high quality and reliable US joint manufacturer. We continued to expand our joint line by launching two new products this year, a Uni Knee and Shoulder. We are a start to finish manufacturing facility from raw materials through sterilization and packaging. We distribute to more than 15 countries worldwide.
Our future is looking bright. In 2015, we founded a medtech division within Consensus named TracPatch. The goal of this division is to use our 25 years of orthopedic experience to create innovative wearable technology for joint replacement rehabilitation and to assist our surgeons through the entire episode of care.
2. Why is Consensus, a traditionally orthopedic implant company, branching out into post-op patient monitoring?
The beginning of TracPatch is an interesting story. I was at a friend’s birthday party and I was talking with an orthopedic surgeon I knew. We were engrossed in the topic of real time post-op patient data. He told me he could “put in the best implant technology, align the joint perfectly, and balance the soft tissues, but if his patient sits on their couch with a pillow under their knee during those critical first six weeks post-operatively, the patient will have a bad result.” The TracPatch spark was lit right then.
From there, we combined our employees’ knowledge of orthopedics and electronics and created the TracPatch Division.
At the same time, CJR was being finalized. So this casual party conversation combined with the market shifting towards a value based model led to our discovering a need for post-op patient monitoring. This was critical to a healthcare providers and/or hospitals success. We leveraged our proximity to Silicon Valley and felt that we could develop products that potentially could improve outcomes, reduce cost and enhance patient satisfaction after total joint surgery. As a result, we created our TracPatch Division, and developed TracPatch, a wearable device for total joint rehabilitation patients.
3. Give me some more details about TracPatch.
TracPatch is a wearable device that can be utilized with any total knee system.  It is placed just below the tibia joint line, medial or lateral to the midline, using a disposable adhesive pad. TracPatch is designed to remotely monitor range of motion, ambulation, exercise compliance, and temperature trends during post-surgical rehabilitation. This machine learning technology strategically optimizes the patient’s entire episode of care with a proactive approach. The TracPatch system includes an app and web dashboard. The app features an intuitive interface for easy operation on any smart phone with Bluetooth technology. The device transmits key data points directly to a secure cloud-based platform, where healthcare providers can track individual patient progress anytime on the app or web dashboard.

4. How can this technology scale for all orthopedic stakeholders?
TracPatch can be used by every patient. I am personally convinced that the benefits of the TracPatch wearable device are so significant that it will become the technology of choice for every surgeon/healthcare provider.
For example, a patient with TracPatch is motivated to engage in their rehabilitation program through daily exercise reminders and an interactive episode of care rehab roadmap. The healthcare provider can know every day if the patient is moving, increasing their range of motion, and completing their rehab exercises. This will in turn have the potential to reduce MUA’s (manipulation under anesthesia), readmissions, and physical therapy sessions; meaning increased value of care with decreased cost of care. These improved outcomes will result in higher patient satisfaction.
5. What kind of impact do you foresee the TracPatch technology having on Consensus as a company?
As I mentioned earlier, Consensus is celebrating our 25th year anniversary. Our products are known for their quality, reliability, and surgeon reproducibility in the OR. This innovative technology allows us to provide a groundbreaking new approach to help healthcare providers reduce costs and increase positive outcomes. TracPatch can add tremendous value to the entire episode of care. This technology delivers never-before-seen data into the post-surgical rehabilitation for healthcare providers. Being able to monitor your patients’ range of motion progress and exercise compliance daily is a game changer. TracPatch is making proactive care easy, so every patient has an excellent outcome. In 2018, we will be releasing a version for the hip as well.
The orthopedic industry has never seen anything like this before and we want to be on the forefront in this budding medtech orthopedic space. It not only allows Consensus Orthopedics to expand our current revenue and customer base, TracPatch also will attract new surgeons and hospitals that don’t currently use our total joints. This technology provides a synergistic market strategy we can use to create a streamlined episode of care.
6. Where do you see this technology going next?
Without giving up too much detail on our IP, Orthopedic wearable technology is the future. TracPatch is just the beginning. I envision wearable technology will completely change the orthopedic industry. Just imagine a future where innovative implant technology, wearable technology, and IoT intersect to create a completely connected care environment. Where provider and patient are synced throughout the entire pre, intra, and post-operative episode of care.

For more information about TracPatch, click here [www.tracpatch.com]or email us at [email protected]
Consensus Orthopedics, Inc.
1115 Windfield Way
El Dorado Hills, CA 95762
www.consensusortho.com

Read More

Technology, Startup News, Career Advice & More

Archives

Pin It on Pinterest

Menu